table of content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Treatments Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Adipose Tissue-Derived Mesenchymal Stem Cells
1.2.3 Bone Marrow-Derived Mesenchymal Stem Cells
1.2.4 Cord Blood/Embryonic Stem Cells
1.2.5 Other Cell Sources
1.3 Market by Application
1.3.1 Global Stem Cell Treatments Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Nerve Diseases
1.3.3 Immunological Diseases
1.3.4 Musculoskeletal Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Gastrointestinal Diseases
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Treatments Market Perspective (2018-2029)
2.2 Stem Cell Treatments Growth Trends by Region
2.2.1 Stem Cell Treatments Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Stem Cell Treatments Historic Market Size by Region (2018-2023)
2.2.3 Stem Cell Treatments Forecasted Market Size by Region (2024-2029)
2.3 Stem Cell Treatments Market Dynamics
2.3.1 Stem Cell Treatments Industry Trends
2.3.2 Stem Cell Treatments Market Drivers
2.3.3 Stem Cell Treatments Market Challenges
2.3.4 Stem Cell Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Treatments Players by Revenue
3.1.1 Global Top Stem Cell Treatments Players by Revenue (2018-2023)
3.1.2 Global Stem Cell Treatments Revenue Market Share by Players (2018-2023)
3.2 Global Stem Cell Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Treatments Revenue
3.4 Global Stem Cell Treatments Market Concentration Ratio
3.4.1 Global Stem Cell Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Treatments Revenue in 2022
3.5 Stem Cell Treatments Key Players Head office and Area Served
3.6 Key Players Stem Cell Treatments Product Solution and Service
3.7 Date of Enter into Stem Cell Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Treatments Breakdown Data by Type
4.1 Global Stem Cell Treatments Historic Market Size by Type (2018-2023)
4.2 Global Stem Cell Treatments Forecasted Market Size by Type (2024-2029)
5 Stem Cell Treatments Breakdown Data by Application
5.1 Global Stem Cell Treatments Historic Market Size by Application (2018-2023)
5.2 Global Stem Cell Treatments Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Stem Cell Treatments Market Size (2018-2029)
6.2 North America Stem Cell Treatments Market Size by Country (2018-2023)
6.3 North America Stem Cell Treatments Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Stem Cell Treatments Market Size (2018-2029)
7.2 Europe Stem Cell Treatments Market Size by Country (2018-2023)
7.3 Europe Stem Cell Treatments Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Treatments Market Size (2018-2029)
8.2 Asia-Pacific Stem Cell Treatments Market Size by Country (2018-2023)
8.3 Asia-Pacific Stem Cell Treatments Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Stem Cell Treatments Market Size (2018-2029)
9.2 Latin America Stem Cell Treatments Market Size by Country (2018-2023)
9.3 Latin America Stem Cell Treatments Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Treatments Market Size (2018-2029)
10.2 Middle East & Africa Stem Cell Treatments Market Size by Country (2018-2023)
10.3 Middle East & Africa Stem Cell Treatments Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics, Inc
11.1.1 Osiris Therapeutics, Inc Company Detail
11.1.2 Osiris Therapeutics, Inc Business Overview
11.1.3 Osiris Therapeutics, Inc Stem Cell Treatments Introduction
11.1.4 Osiris Therapeutics, Inc Revenue in Stem Cell Treatments Business (2018-2023)
11.1.5 Osiris Therapeutics, Inc Recent Development
11.2 MEDIPOST Co., Ltd
11.2.1 MEDIPOST Co., Ltd Company Detail
11.2.2 MEDIPOST Co., Ltd Business Overview
11.2.3 MEDIPOST Co., Ltd Stem Cell Treatments Introduction
11.2.4 MEDIPOST Co., Ltd Revenue in Stem Cell Treatments Business (2018-2023)
11.2.5 MEDIPOST Co., Ltd Recent Development
11.3 JCR Pharmaceuticals Co., Ltd
11.3.1 JCR Pharmaceuticals Co., Ltd Company Detail
11.3.2 JCR Pharmaceuticals Co., Ltd Business Overview
11.3.3 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Introduction
11.3.4 JCR Pharmaceuticals Co., Ltd Revenue in Stem Cell Treatments Business (2018-2023)
11.3.5 JCR Pharmaceuticals Co., Ltd Recent Development
11.4 FUJIFILM Cellular Dynamics, Inc.
11.4.1 FUJIFILM Cellular Dynamics, Inc. Company Detail
11.4.2 FUJIFILM Cellular Dynamics, Inc. Business Overview
11.4.3 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Introduction
11.4.4 FUJIFILM Cellular Dynamics, Inc. Revenue in Stem Cell Treatments Business (2018-2023)
11.4.5 FUJIFILM Cellular Dynamics, Inc. Recent Development
11.5 Holostem Terapie Avanzate S.r.l.
11.5.1 Holostem Terapie Avanzate S.r.l. Company Detail
11.5.2 Holostem Terapie Avanzate S.r.l. Business Overview
11.5.3 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Introduction
11.5.4 Holostem Terapie Avanzate S.r.l. Revenue in Stem Cell Treatments Business (2018-2023)
11.5.5 Holostem Terapie Avanzate S.r.l. Recent Development
11.6 Athersys Inc.
11.6.1 Athersys Inc. Company Detail
11.6.2 Athersys Inc. Business Overview
11.6.3 Athersys Inc. Stem Cell Treatments Introduction
11.6.4 Athersys Inc. Revenue in Stem Cell Treatments Business (2018-2023)
11.6.5 Athersys Inc. Recent Development
11.7 CORESTEM, Inc
11.7.1 CORESTEM, Inc Company Detail
11.7.2 CORESTEM, Inc Business Overview
11.7.3 CORESTEM, Inc Stem Cell Treatments Introduction
11.7.4 CORESTEM, Inc Revenue in Stem Cell Treatments Business (2018-2023)
11.7.5 CORESTEM, Inc Recent Development
11.8 Mesoblast Ltd.
11.8.1 Mesoblast Ltd. Company Detail
11.8.2 Mesoblast Ltd. Business Overview
11.8.3 Mesoblast Ltd. Stem Cell Treatments Introduction
11.8.4 Mesoblast Ltd. Revenue in Stem Cell Treatments Business (2018-2023)
11.8.5 Mesoblast Ltd. Recent Development
11.9 Regenexx
11.9.1 Regenexx Company Detail
11.9.2 Regenexx Business Overview
11.9.3 Regenexx Stem Cell Treatments Introduction
11.9.4 Regenexx Revenue in Stem Cell Treatments Business (2018-2023)
11.9.5 Regenexx Recent Development
11.10 Reliance Life Sciences Private Limited
11.10.1 Reliance Life Sciences Private Limited Company Detail
11.10.2 Reliance Life Sciences Private Limited Business Overview
11.10.3 Reliance Life Sciences Private Limited Stem Cell Treatments Introduction
11.10.4 Reliance Life Sciences Private Limited Revenue in Stem Cell Treatments Business (2018-2023)
11.10.5 Reliance Life Sciences Private Limited Recent Development
11.11 U.S. Stem Cell, Inc.
11.11.1 U.S. Stem Cell, Inc. Company Detail
11.11.2 U.S. Stem Cell, Inc. Business Overview
11.11.3 U.S. Stem Cell, Inc. Stem Cell Treatments Introduction
11.11.4 U.S. Stem Cell, Inc. Revenue in Stem Cell Treatments Business (2018-2023)
11.11.5 U.S. Stem Cell, Inc. Recent Development
11.12 Vericel Corporation
11.12.1 Vericel Corporation Company Detail
11.12.2 Vericel Corporation Business Overview
11.12.3 Vericel Corporation Stem Cell Treatments Introduction
11.12.4 Vericel Corporation Revenue in Stem Cell Treatments Business (2018-2023)
11.12.5 Vericel Corporation Recent Development
11.13 Pharmicell Co., Ltd
11.13.1 Pharmicell Co., Ltd Company Detail
11.13.2 Pharmicell Co., Ltd Business Overview
11.13.3 Pharmicell Co., Ltd Stem Cell Treatments Introduction
11.13.4 Pharmicell Co., Ltd Revenue in Stem Cell Treatments Business (2018-2023)
11.13.5 Pharmicell Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
